Identification of IL18/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes.

iScience · 2025 · PMC12529506 · PMID 41111914

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When examining individual clinical outcomes, circulating IL-18R1 levels significantly predicted weight response (AUC = 0.644, p = 0.03), while associations with changes in HbA1c and UACR did not reach statistical significance ( Figure 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.